Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04805229 · ClinicalTrials.gov registry record

A Difference-In-Differences Analysis of New Persistent Opioid Use After Surgery

A clinical trial of Opioid Use, sponsored by University of Michigan.

Completed
Registry status
30,000
Enrollment target
1
Study location

NCT04805229 is a study of Opioid Use that has completed, run by University of Michigan. The registered enrollment target is 30,000 participants, below the 147,974-participant average among 105 other Opioid Use trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04805229, a study of Opioid Use, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
30,000 participants
Enrollment target
1
Study location

Study Summary

The Michigan Opioid Prescribing and Engagement Network (M-OPEN) was established in 2016 with the goal of reducing excessive opioid prescribing after surgery using evidence-based prescribing guidelines. Beginning in July 2016, M-OPEN began a statewide quality improvement campaign to educate providers and share prescribing best practices. This retrospective study examines the effect of these efforts on new persistent opioid use after surgery compared to other states where no such program existed using a difference-in-differences approach.

Conditions Studied

Interventions

  • OTHER Retrospective analysis of opioid use after surgery

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 30,000 participants
Start Date 2013-01-01
Est. Completion 2019-12-31

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT04805229

The ClinicalTrials.gov registry entry for NCT04805229 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 147,974-participant average among 105 other Opioid Use trials with a reported enrollment target (80% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use appearing as the primary indexed condition, and to 1 intervention - of which Retrospective analysis of opioid use after surgery is the first listed.

NCT04805229 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT04805229 about?

NCT04805229 is a clinical study titled "A Difference-In-Differences Analysis of New Persistent Opioid Use After Surgery". The Michigan Opioid Prescribing and Engagement Network (M-OPEN) was established in 2016 with the goal of reducing excessive opioid prescribing after surgery using evidence-based prescribing guidelines. Beginning in July 2016, M-OPEN began a statewide quality improvement campaign to educate providers...

What is the current status of trial NCT04805229?

This trial is currently completed. The enrollment target is 30,000 participants. The study started on 2013-01-01. Estimated completion is 2019-12-31.

What conditions does trial NCT04805229 study?

This clinical trial studies the following conditions: Opioid Use.

What interventions are being tested in trial NCT04805229?

The interventions under investigation include: Retrospective analysis of opioid use after surgery (OTHER).

Who is sponsoring clinical trial NCT04805229?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04805229 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.